Archana Singh-Manoux1, Annie R Britton, Michael Marmot. 1. International Center for Health and Society, Department of Epidemiology and Public Health, University College, London, United Kingdom. A.Singh-Manoux@public-health.ucl.ac.uk
Abstract
OBJECTIVES: : To test the hypothesis of an inverse association between indicators of vascular disease and cognitive function in the general, stroke-free population. DESIGN: : A longitudinal, British civil service-based cohort study. Measures of vascular disease examined were prevalent at baseline or traced over a median of 11 years, between Phases 1 (1985-1988) and 5 (1997-1999) of data collection. Cognitive function was assessed at Phase 5 of data collection. SETTING: : Twenty London-based Civil Service departments. PARTICIPANTS: : Four thousand one hundred forty-one men and 1,681 women, aged 46 to 68 when tested for cognitive function. MEASUREMENTS: : A battery of cognitive tests consisting of: memory test, Alice Heim 4, Mill-Hill, phonemic, and semantic fluency. RESULTS: : The occurrence of angina pectoris (P<.001), myocardial infarction (P=.02), all coronary heart disease (P<.001), and intermittent claudication (P=.004) was associated with poor cognitive function. These effects were independent of age and socioeconomic status. The association between indicators of vascular disease and cognitive function applied to the entire range of cognitive function measures examined in the study. CONCLUSION: : The findings support the view that vascular disease is predictive of poor cognitive function in the general population. The fact that presence of vascular disease was associated with diminished cognitive function even in a relatively young cohort has implications for the management of vascular disease.
OBJECTIVES: : To test the hypothesis of an inverse association between indicators of vascular disease and cognitive function in the general, stroke-free population. DESIGN: : A longitudinal, British civil service-based cohort study. Measures of vascular disease examined were prevalent at baseline or traced over a median of 11 years, between Phases 1 (1985-1988) and 5 (1997-1999) of data collection. Cognitive function was assessed at Phase 5 of data collection. SETTING: : Twenty London-based Civil Service departments. PARTICIPANTS: : Four thousand one hundred forty-one men and 1,681 women, aged 46 to 68 when tested for cognitive function. MEASUREMENTS: : A battery of cognitive tests consisting of: memory test, Alice Heim 4, Mill-Hill, phonemic, and semantic fluency. RESULTS: : The occurrence of angina pectoris (P<.001), myocardial infarction (P=.02), all coronary heart disease (P<.001), and intermittent claudication (P=.004) was associated with poor cognitive function. These effects were independent of age and socioeconomic status. The association between indicators of vascular disease and cognitive function applied to the entire range of cognitive function measures examined in the study. CONCLUSION: : The findings support the view that vascular disease is predictive of poor cognitive function in the general population. The fact that presence of vascular disease was associated with diminished cognitive function even in a relatively young cohort has implications for the management of vascular disease.
Authors: Gail A Laughlin; Linda K McEvoy; Denise von Mühlen; Lori B Daniels; Donna Kritz-Silverstein; Jaclyn Bergstrom; Kevin Cummins; Claudia Der-Martirosian; Simerjot K Jassal; Elizabeth Barrett-Connor Journal: Psychosom Med Date: 2011-09-23 Impact factor: 4.312
Authors: John Gunstad; Linda Bausserman; Robert H Paul; David F Tate; Karin Hoth; Athena Poppas; Angela L Jefferson; Ronald A Cohen Journal: J Clin Neurosci Date: 2006-05-24 Impact factor: 1.961
Authors: Archana Singh-Manoux; David Gimeno; Mika Kivimaki; Eric Brunner; Michael G Marmot Journal: Arterioscler Thromb Vasc Biol Date: 2008-06-30 Impact factor: 8.311
Authors: Andrea L C Schneider; Albert Richey Sharrett; Rebecca F Gottesman; Josef Coresh; Laura Coker; Lisa Wruck; Ola A Selnes; Jennifer Deal; David Knopman; Thomas H Mosley Journal: Alzheimer Dis Assoc Disord Date: 2015 Jan-Mar Impact factor: 2.703
Authors: Marko Elovainio; Andrew Sommerlad; Christian Hakulinen; Laura Pulkki-Råback; Marianna Virtanen; Mika Kivimäki; Archana Singh-Manoux Journal: Int J Epidemiol Date: 2018-06-01 Impact factor: 7.196
Authors: Rosebud O Roberts; David S Knopman; Yonas E Geda; Ruth H Cha; Véronique L Roger; Ronald C Petersen Journal: Neurobiol Aging Date: 2008-12-16 Impact factor: 4.673
Authors: Carrington Rice Wendell; Alan B Zonderman; E Jeffrey Metter; Samer S Najjar; Shari R Waldstein Journal: Stroke Date: 2009-07-30 Impact factor: 7.914